Composition for enhancing immunity or preventing or treating neurodegenerative diseases by using goji berries, mulberries and jujubes
The present invention relates to a composition for enhancing immunity or a composition for preventing or ameliorating neurodegenerative diseases, both of which contain, as an active ingredient, a mixture extract of goji berries, mulberries and jujubes or an extract mixture thereof.
1. A method for enhancing immunity, the method comprising consuming an effective concentration of a composition consisting essentially of a mixture extract of goji berry, mulberry, and jujube as an active ingredient in the form of a pharmaceutical composition or in the form of a health functional food to enhance immunity by increasing macrophage-derived TNF-α expression and
wherein the mixture extract is prepared by
S1) mixing goji berry, mulberry, and jujube in a weight ratio of about 1:1:0.5;
S2) adding water to the mixture of step S1) and extracting water at a temperature from about 70° C. to about 100° C.; and
S3) concentrating the product of step S2) to form a mixture extract.
2. The method for enhancing immunity according to claim 1 , further comprising lyophilizing or spray drying the mixture extract and/or mixing an additive with the mixture extract, wherein the additive comprises a carrier, an excipient, a diluent, an extender, a binder, a wetting agent, a disintegrating agent, a surfactant, a lubricant, or a combination thereof.
3. The method for enhancing immunity according to claim 1 comprising administering the pharmaceutical composition at a dose of 0.0001 to 2,000 mg/kg per day.
4. The method for enhancing immunity according to claim 1 , wherein the effective concentration is from about 1 μg/ml to about 10 mg/ml.
5. The method for enhancing immunity according to claim 1 , wherein the composition further comprises one or more additives selected from a carrier, an excipient, a diluent, an extender, a binder, a wetting agent, a disintegrating agent, a surfactant, or a lubricant.
6. The method of claim 1 wherein the extracting is performed for at least 1 hour.
7. The method of claim 1 wherein the extracting is performed for about 3 hours to about 10 hours and wherein the extracting is performed 2 or 3 times.
8. A method for treating, or ameliorating neurodegenerative diseases, the method comprising consuming an effective concentration of a composition consisting essentially of a mixture extract of goji berry, mulberry, and jujube in the form of a pharmaceutical composition to prevent or treat neurodegenerative diseases or in the form of a health functional food to prevent or ameliorate neurodegenerative diseases, wherein the effective concentration of the composition increases the ratio of mBDNF (mature BDNF) to hippocampal total BDNF and wherein the mixture extract is prepared by
S1) mixing goji berry, mulberry, and jujube in a weight ratio of about 1:1:0.5;
S2) adding water to the mixture of step S1) and extracting water at a temperature from about 70° C. to about 100° C.; and
S3) concentrating the product of step S2) to form a mixture extract.
9. The method for treating, or ameliorating neurodegenerative diseases according to claim 8 , further comprising lyophilizing or spray drying the mixture extract and/or mixing an additive with the mixture extract, wherein the additive comprises a carrier, an excipient, a diluent, an extender, a binder, a wetting agent, a disintegrating agent, a surfactant, a lubricant, or a combination thereof.
10. The method for treating, or ameliorating neurodegenerative diseases according to claim 8 , wherein the effective concentration is from about 1 μg/ml to about 10 mg/ml.
11. The method for treating, or ameliorating neurodegenerative diseases method according to claim 8 , wherein the composition further comprises one or more additives selected from a carrier, an excipient, a diluent, an extender, a binder, a wetting agent, a disintegrating agent, a surfactant, or a lubricant.
12. The method for treating, or ameliorating neurodegenerative diseases according to claim 8 , wherein the neurodegenerative disease is Alzheimer's disease.